Robby Moot

Robby Moot is currently the Associate Director at ArsenalBio. Prior to this, Robby held various titles at PACT Pharma, focusing on synthesizing neo-epitope targeted T cells for personalized adoptive cell therapy for cancer patients. Robby also has experience in translational immunology and gene editing. With a background in molecular and systems pharmacology, Robby has been involved in developing novel immunotherapy methods for cancer treatment and gene therapy approaches for diseases such as hemophilia A. Moot's research experience spans various organizations including Emory University, Aflac Cancer and Blood Disorders Center, and Expression Therapeutics. Moot also has a Bachelor of Science in Biology/Biological Sciences from The University of Georgia.